LOGIN  |  REGISTER
Surmodics

Recent Insider Transactions - Arcutis Biotherapeutics (NASDAQ: ARQT)

Follow NASDAQ:ARQT Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ARQT Arcutis Biotherapeutics
Topper David Joseph / officer: Chief Financial Officer
04/10/2024
Buy
$12.34
310,000
$3.825M
310,000
NASDAQ ARQT Arcutis Biotherapeutics
Topper David Joseph / officer: Chief Financial Officer
04/10/2024
Sell
$2.54
7,500
$19K
0
NASDAQ ARQT Arcutis Biotherapeutics
Matsuda Masaru / officer: See Remark
03/04/2024
Sell
$11.12
3,760
$42K
190,424
NASDAQ ARQT Arcutis Biotherapeutics
Burnett Patrick / officer: See Remarks
03/04/2024
Sell
$11.12
4,782
$53K
269,300
NASDAQ ARQT Arcutis Biotherapeutics
Watanabe Todd Franklin / director, officer: See Remarks
03/04/2024
Sell
$11.12
14,903
$166K
874,533
NASDAQ ARQT Arcutis Biotherapeutics
Moore Matthew Richard / officer: SVP and Chief Business Officer
03/04/2024
Sell
$11.12
3,468
$39K
146,020
NASDAQ ARQT Arcutis Biotherapeutics
Heron Patrick J / director
03/04/2024
Buy
$9.50
21,052
$200K
8.79M
NASDAQ ARQT Arcutis Biotherapeutics
Watanabe Todd Franklin / director, officer: See Remarks
02/28/2024
Sell
$10.60
2,465
$26K
889,436
NASDAQ ARQT Arcutis Biotherapeutics
Moore Matthew Richard / officer: SVP and Chief Business Officer
02/13/2024
Sell
$28.72
12,500
$359K
0
NASDAQ ARQT Arcutis Biotherapeutics
Moore Matthew Richard / officer: SVP and Chief Business Officer
02/13/2024
Sell
$17.67
35,300
$624K
0
NASDAQ ARQT Arcutis Biotherapeutics
Moore Matthew Richard / officer: SVP and Chief Business Officer
02/13/2024
Sell
$15.82
39,500
$625K
0
NASDAQ ARQT Arcutis Biotherapeutics
Burnett Patrick / officer: See Remarks
02/13/2024
Sell
$32.44
28,800
$934K
0
NASDAQ ARQT Arcutis Biotherapeutics
Burnett Patrick / officer: See Remarks
02/13/2024
Sell
$15.82
55,800
$883K
0
NASDAQ ARQT Arcutis Biotherapeutics
Burnett Patrick / officer: See Remarks
02/13/2024
Sell
$17.67
47,100
$832K
0
NASDAQ ARQT Arcutis Biotherapeutics
Burnett Patrick / officer: See Remarks
02/13/2024
Sell
$25.89
320,000
$8.285M
0
NASDAQ ARQT Arcutis Biotherapeutics
Matsuda Masaru / officer: See Remark
02/13/2024
Sell
$17.67
35,300
$624K
0
NASDAQ ARQT Arcutis Biotherapeutics
Matsuda Masaru / officer: See Remark
02/13/2024
Sell
$22.79
185,000
$4.216M
0
NASDAQ ARQT Arcutis Biotherapeutics
Matsuda Masaru / officer: See Remark
02/13/2024
Sell
$15.82
55,800
$883K
0
NASDAQ ARQT Arcutis Biotherapeutics
Watanabe Todd Franklin / director, officer: See Remarks
02/13/2024
Sell
$15.82
232,200
$3.673M
0
NASDAQ ARQT Arcutis Biotherapeutics
Watanabe Todd Franklin / director, officer: See Remarks
02/13/2024
Sell
$27.61
65,000
$1.795M
0
NASDAQ ARQT Arcutis Biotherapeutics
Watanabe Todd Franklin / director, officer: See Remarks
02/13/2024
Sell
$32.44
99,200
$3.218M
0
NASDAQ ARQT Arcutis Biotherapeutics
Watanabe Todd Franklin / director, officer: See Remarks
02/13/2024
Sell
$17.67
188,100
$3.324M
0
NASDAQ ARQT Arcutis Biotherapeutics
Smither John W / officer: Chief Financial Officer
02/13/2024
Sell
$27.61
8,379
$231K
0
NASDAQ ARQT Arcutis Biotherapeutics
Smither John W / officer: Chief Financial Officer
02/13/2024
Sell
$32.44
25,718
$834K
0
NASDAQ ARQT Arcutis Biotherapeutics
Burnett Patrick / officer: See Remarks
01/12/2024
Buy
$3.64
276,000
$1.005M
276,000
NASDAQ ARQT Arcutis Biotherapeutics
Edwards Larry Todd / officer: Chief Commercial Officer
01/12/2024
Buy
$3.64
176,000
$641K
176,000
NASDAQ ARQT Arcutis Biotherapeutics
Matsuda Masaru / officer: See Remark
01/12/2024
Buy
$3.64
176,000
$641K
176,000
NASDAQ ARQT Arcutis Biotherapeutics
Watanabe Todd Franklin / director, officer: See Remarks
01/12/2024
Buy
$3.64
410,000
$1.492M
410,000
NASDAQ ARQT Arcutis Biotherapeutics
Moore Matthew Richard / officer: SVP and Chief Business Officer
01/12/2024
Buy
$3.64
126,000
$459K
126,000
NASDAQ ARQT Arcutis Biotherapeutics
Burnett Patrick / officer: See Remarks
01/02/2024
Sell
$3.54
1,325
$5K
57,032
NASDAQ ARQT Arcutis Biotherapeutics
Watanabe Todd Franklin / director, officer: See Remarks
05/31/2023
Buy
$6.38
1,463
$9K
515,145
NASDAQ ARQT Arcutis Biotherapeutics
Watanabe Todd Franklin / director, officer: See Remarks
12/01/2023
Buy
$1.68
59,525
$100K
513,682
NASDAQ ARQT Arcutis Biotherapeutics
Watanabe Todd Franklin / director, officer: See Remarks
12/01/2023
Sell
$1.68
59,525
$100K
49,823
NASDAQ ARQT Arcutis Biotherapeutics
Matsuda Masaru / officer: See Remark
11/21/2023
Sell
$1.98
1,850
$4K
46,634
NASDAQ ARQT Arcutis Biotherapeutics
Frazier Life Sciences VIII, L.P. / 10 percent owner
10/24/2023
Buy
$2.50
80,000
$200K
8.76M
NASDAQ ARQT Arcutis Biotherapeutics
Edwards Larry Todd / officer: Chief Commercial Officer
09/27/2023
Buy
$5.58
240,000
$1.339M
240,000
NASDAQ ARQT Arcutis Biotherapeutics
Moore Matthew Richard / officer: SVP and Chief Business Officer
08/29/2023
Buy
$28.72
12,500
$359K
12,500
NASDAQ ARQT Arcutis Biotherapeutics
Smither John W / officer: Chief Financial Officer
08/31/2023
Buy
$8.54
125,000
$1.068M
125,000
NASDAQ ARQT Arcutis Biotherapeutics
Smither John W / officer: Chief Financial Officer
08/31/2023
Sell
$1.68
40,482
$68K
0
NASDAQ ARQT Arcutis Biotherapeutics
Smither John W / officer: Chief Financial Officer
08/31/2023
Sell
$27.61
8,379
$231K
0
NASDAQ ARQT Arcutis Biotherapeutics
Smither John W / officer: Chief Financial Officer
08/31/2023
Sell
$32.44
25,718
$834K
0
NASDAQ ARQT Arcutis Biotherapeutics
Smither John W / officer: Chief Financial Officer
08/31/2023
Sell
$6.52
4,165
$27K
0
NASDAQ ARQT Arcutis Biotherapeutics
Burnett Patrick / officer: See Remarks
08/21/2023
Sell
$7.05
300
$2K
59,662
NASDAQ ARQT Arcutis Biotherapeutics
Burnett Patrick / officer: See Remarks
08/21/2023
Sell
$7.04
1,305
$9K
58,357
NASDAQ ARQT Arcutis Biotherapeutics
Matsuda Masaru / officer: See Remark
05/31/2023
Buy
$6.38
1,463
$9K
43,609
NASDAQ ARQT Arcutis Biotherapeutics
Matsuda Masaru / officer: See Remark
05/31/2023
Sell
$7.80
1,830
$14K
42,146
NASDAQ ARQT Arcutis Biotherapeutics
LIN SUE-JEAN / director
05/31/2023
Buy
$7.51
12,220
$92K
12,220
NASDAQ ARQT Arcutis Biotherapeutics
Heron Patrick J / director, 10 percent owner:
05/31/2023
Buy
$7.51
12,220
$92K
12,220
NASDAQ ARQT Arcutis Biotherapeutics
CHAUDHURI BHASKAR / director
05/31/2023
Buy
$7.51
12,220
$92K
12,220
NASDAQ ARQT Arcutis Biotherapeutics
Curran Terrie / director
05/31/2023
Buy
$7.51
12,220
$92K
12,220
NASDAQ ARQT Arcutis Biotherapeutics
Gilbert Halley E / director
05/31/2023
Buy
$7.51
12,220
$92K
12,220
NASDAQ ARQT Arcutis Biotherapeutics
Leonard Keith R / director
05/31/2023
Buy
$7.51
12,220
$92K
12,220
NASDAQ ARQT Arcutis Biotherapeutics
Krishnamohan Neha / director
05/31/2023
Buy
$7.51
12,220
$92K
12,220
NASDAQ ARQT Arcutis Biotherapeutics
Welgus Howard G. / director
05/31/2023
Buy
$7.51
12,220
$92K
12,220
NASDAQ ARQT Arcutis Biotherapeutics
Welgus Howard G. / director
04/17/2023
Buy
$1.68
8,500
$14K
174,325
NASDAQ ARQT Arcutis Biotherapeutics
Welgus Howard G. / director
04/17/2023
Sell
$13.97
8,500
$119K
165,825
NASDAQ ARQT Arcutis Biotherapeutics
Welgus Howard G. / director
04/17/2023
Sell
$1.68
8,500
$14K
6,458
NASDAQ ARQT Arcutis Biotherapeutics
Welgus Howard G. / director
04/06/2023
Buy
$1.68
8,500
$14K
174,325
NASDAQ ARQT Arcutis Biotherapeutics
Welgus Howard G. / director
04/06/2023
Sell
$12.01
8,500
$102K
165,825
NASDAQ ARQT Arcutis Biotherapeutics
Welgus Howard G. / director
04/06/2023
Sell
$1.68
8,500
$14K
14,958

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous